BCL2L1 and breast cancer: We detected predominant nuclear Bcl-xL in 3 of 15 cases of breast cancer specimens (Figure 1a, 1b, and data not shown) and weak nuclear Bcl-xL in the other cases (Figure 1c and data not shown), suggesting that Bcl-xL can also be translocated into the nucleus of the breast cancer cells.